Pelacarsen
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Pelacarsen, covering 2024-10-09 to 2026-07-17. Get the full timeline:
Most recent: Clinical Trial Results: A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in Germany [Phase 3]